Loading company…
Multiply Labs builds robotic systems for industrial-scale manufacturing of gene-modified cell therapies and precision medicines.
Founded in 2016 by Fred Parietti and Alice Melocchi and based in San Francisco, US, Multiply Labs, Inc. develops robotic manufacturing systems for gene-modified cell therapies. Revenue comes from selling or leasing systems with service agreements, mainly with biotech and pharmaceutical firms. In October 2026 it raised USD 75 million in Series B funding led by NantVentures, with participation from AstraZeneca, Teradyne Inc., Lux Capital and others.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in